TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants With Clinical Significant Abnormal Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in total IPSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of demands for oral opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major adverse cardiovascular event
Endpoint domain: Mortality/survival
Primary endpoint: Change-from-baseline in Serum Lactate Dehydrogenase (LDH) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Intraocular Pressure Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Radiation-induced Pain Flare Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-Related Potentials (ERP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Selective Reminding Test (SRT) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brief Visuospatial Memory Test-Revised (BVMT-R) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: 2- second and 3-second Paced Auditory Serial Addition Test (PASAT) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Symbol Digit Modalities Test (SDMT) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in infants' height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in infants' weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression Severity Rating Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients alive and operated on without grade 4 toxicity
Endpoint domain: Mortality/survival
Primary endpoint: Drop in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Gait Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance rate for adjuvant AI medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Report Knowledge of Mental Illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Report Attitudes Towards Mental Illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: System usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in insomnia severity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in average sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: safety assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebrospinal Fluid (CSF) T-tau Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebrospinal Fluid (CSF) P-tau 181 Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tear meniscus volume after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opiate withdrawal severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dietary energy and nutrient intakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in appetite sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with completed Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cutaneous JAK expression in relation to disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reactive hyperemia measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis performance of FFOCT for cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in fatigue level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Latrine Usage Rate
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total dose of PCA analgesics required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hypertonic saline PD20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ventilator free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of chronic GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Comparison of filter effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Particles in Exhaled Air (Surfactant Protein A & Albumin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Alterations in immune response to flu antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: femoral head bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in weekly time in moderate-to-vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily time using TV/computer/cellular/video games
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of participants with MACCE Events
Endpoint domain: Mortality/survival
Primary endpoint: Rate of participants in whom technical success was achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Death
Endpoint domain: Mortality/survival
Primary endpoint: Change in Total Functional Capacity Score (TFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy value of the ration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total carbohydrate consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total protein consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dietary fibre consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: General impression at last visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Elimination rate of post-prandial fullness, upper abdominal bloating and early satiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence and severity of ocular and non ocular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Montreal Cognitive Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frontal Assessment Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: DSM-5 severity of stimulant use disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TcNC100692 uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Clinical Attachment Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED50 After Phenylephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clearance of ammonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of production of ammonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence of Pterygia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subclinical infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hypoxic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of the nursing, medical team and patients with the implemented system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: efficacy of SP01A treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of SP01A treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline to Week 6 in Framingham Predicted Absolute 10-year Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative 24 hours cumulative rescue morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biochemical progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: All cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: Count of Participants With a Grade >=3 Adverse Event (AE) or Grade >=1 Immune-related AE (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Count of Participants With a Grade >=1 irAE Related to Study Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Diffusion weighted magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of concomitant criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in breath test signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Maintenance Insomnia (pr-WASO)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: quality of pain relief at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of pain relief at movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urination frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Ectopic pregnancy rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of sick-leave days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cancer-specific health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bone metastases related health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with Dose-limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of response (DOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total 14C radioactivity in urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initiation and completion of primary treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Functional Ambulation Scale (FAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak mitral annular velocity during systole (S')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak mitral annular velocity during early filling (E')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak mitral annular velocity during atrial contraction (A')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: arterial ammonia concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of latent TB infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tumor response by RECIST criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Phase angle (θ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Methane Production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4 month progression free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: NERD Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspartate Aminotransferase (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Alanine Aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of C Reactive Protein (CRP) at 24 hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants Classified as Having Made an Informed Decision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in CD4+ T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Toronto Rehabilitation Institute Hand Function Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial elongation in 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back Surface Lens Deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Assessment Questionnaire-Asthma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma Area Under Curve (AUC 0-12 hr) for Raltegravir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent pulmonary embolism (PE)
Endpoint domain: Mortality/survival
Primary endpoint: Agreement in assessment of ICU patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcomes post-procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suitability of Point of Care INR testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction accuracy of embryos reaching blastocyst stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of Subjects With Acromegaly With a Normalised IGF-1 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Fatigability of the knee extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in single muscle fiber function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in muscle volume of the quadricep muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in muscle metabolism during a fatiguing knee extensor exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in vascular function via flow-mediated dilation of the femoral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of serious events
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intercostal arterial bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Thyroidectomy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acute Bone Cell Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Participants With Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reaching Primary Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall Remission Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experienced Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Leak data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from first evaluation on the Michigan Hand Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from first evaluation on the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from first evaluation on the Sollerman Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Anastomosis Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bile acid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in St Marks incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of PGE2, COX-2 and 15-PGDH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed Pain Scores on 50-foot Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Observed Pain Scores on 50-foot Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shifts From Extension Study Baseline in Range of Motion Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quantification of autophagy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h Systolic and Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in the score of Stand-Walk-Sit Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of anogenital warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Anogenital HPV DNA positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mucosal HPV seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Death following admission to the ICU
Endpoint domain: Mortality/survival
Primary endpoint: rate of treatment failure
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline HS thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with adequate relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of subarachnoid anesthesia assessed by the pinprick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of subarachnoid anesthesia assessed by the modified Bromage scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of subarachnoid anesthesia assessed by the time of motor block establishment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical Bone Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Bone Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DXA Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: administered dose of propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of subjective knee status evaluated with EQ-5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of subjective knee status evaluated with KOOS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of subjective knee status on Tegner activity scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Severity of PTSD Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients with Dose Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: GC007F persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of mammography screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metastasis and/or recurrence of gastric carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Change in Forward Propulsion of the Paretic Limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interdialytic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gestational Age at Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Classification accuracy of heart rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Radiation Dermatitis
Endpoint domain: Adverse events/effects